Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:04
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:02
Viva Biotech (1873.HK) Announces 2023 Interim Results：Solid Growth in Main Business, Significant Rebound in Profitability 2023-08-29 22:38
Akeso Announced Completion of Patient Enrollment in Phase 3 Trial of Ivonescimab (PD-1/VEGF) versus Pembrolizumab in First-line PD-L1 Positive Advanced NSCLC 2023-08-29 20:00
Bayer Launches Stunting Prevention Program "CETING" for Community of Cisalak, Depok 2023-08-29 13:53
ProfoundBio to Participate in the 21st Annual Morgan Stanley Conference 2023-08-28 20:00
Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines 2023-08-28 19:00
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress 2023-08-28 11:08
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy 2023-08-28 04:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial 2023-08-25 20:58
Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA 2023-08-25 20:00
Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline 2023-08-25 19:37
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth 2023-08-25 19:26
Tigermed Reports 2023 Interim Results 2023-08-25 18:39
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 2023-08-25 15:14
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced 2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy 2023-08-25 08:15
Antheia Achieves Major Commercial Milestone 2023-08-25 08:01
1 83 84 85 86 87 413